Randomized phase 2 trial of white button mushroom supplement in biochemically recurrent prostate cancer
Prostate Adenocarcinoma · PSA Progression
Enrolment: 133 · Results not recorded
Nutraceutical
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Prostate Adenocarcinoma · PSA Progression
Enrolment: 133 · Results not recorded
Prostate Cancer
Enrolment: 36 · Results not recorded
Breast Cancer
Enrolment: 16 · Results not recorded
Immune Response
Enrolment: 88 · Results not recorded
Breast Carcinoma
Enrolment: 26 · Results not recorded
Hypercholesterolemia · Postprandial Hyperglycemia
Enrolment: 16 · Results not recorded
1 studies reported at therapy level; 1 evidence entries itemised.
Model: Carbon tetrachloride-induced acute liver injury
FPS significantly lowered liver index, serum GGT, ALT, ALP and AST and hepatic malondialdehyde, raised hepatic glutathione and superoxide dismutase, alleviated histological liver damage and reduced TGF-beta1 and Smad3 expression.
Extraction: extract · Supplied extraction confidence: 0.62. Machine-extracted fields require source verification.